Hall E J
Center for Radiological Research, College of Physicians and Surgeons of Columbia University, New York, NY 10032.
Cancer. 1993 Jun 1;71(11):3753-66. doi: 10.1002/1097-0142(19930601)71:11<3753::aid-cncr2820711145>3.0.co;2-b.
Nine decades have elapsed since Pierre Curie performed the first radiobiologic experiment when he used a radium tube to produce an ulcer on his arm and charted its progress and ultimate healing. A wide range of topics have been investigated in experimental radiation biology from chromosomal aberrations to fractionation effects in normal tissues to the use of neutrons and bioreductive drugs. Many of the strategies used in clinical radiation therapy, including hyperfractionation and accelerated treatment, are firmly based on laboratory experiments conducted in the past. Much current research is focused on understanding the molecular genetics of cancer to identify the genes that are activated or deleted in cells exposed to radiation. Radiobiology has played a key role in shaping radiation therapy into the vigorous, scientifically based, and highly quantitative branch of medicine that it is currently. In addition, research is preparing the field for the future when treatment protocols must be based on molecular rather than cellular biology.
自皮埃尔·居里进行首次放射生物学实验以来,已经过去了九十年。当时他用镭管在自己手臂上制造溃疡,并记录其发展过程和最终愈合情况。在实验放射生物学领域,人们研究了广泛的课题,从染色体畸变到正常组织的分次照射效应,再到中子和生物还原药物的应用。临床放射治疗中使用的许多策略,包括超分割和加速治疗,都牢固地基于过去进行的实验室实验。当前许多研究集中在理解癌症的分子遗传学,以确定在接受辐射的细胞中被激活或缺失的基因。放射生物学在将放射治疗塑造成目前这样一个充满活力、以科学为基础且高度量化的医学分支方面发挥了关键作用。此外,研究正在为未来做准备,届时治疗方案必须基于分子生物学而非细胞生物学。